GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xenon Pharmaceuticals Inc (FRA:XP0) » Definitions » Cyclically Adjusted Book per Share

Xenon Pharmaceuticals (FRA:XP0) Cyclically Adjusted Book per Share : €4.17 (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Xenon Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Xenon Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2025 was €8.502. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €4.17 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Xenon Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 37.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-27), Xenon Pharmaceuticals's current stock price is €26.20. Xenon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €4.17. Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 6.28.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Xenon Pharmaceuticals was 26.02. The lowest was 6.56. And the median was 17.86.


Xenon Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Xenon Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xenon Pharmaceuticals Cyclically Adjusted Book per Share Chart

Xenon Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.74 3.78

Xenon Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.15 3.43 3.78 4.17

Competitive Comparison of Xenon Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Xenon Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xenon Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=8.502/129.1809*129.1809
=8.502

Current CPI (Mar. 2025) = 129.1809.

Xenon Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201506 -5.213 100.500 -6.701
201509 -5.212 100.421 -6.705
201512 3.895 99.947 5.034
201603 -5.647 101.054 -7.219
201606 -5.940 102.002 -7.523
201609 -5.158 101.765 -6.548
201612 3.378 101.449 4.301
201703 -6.060 102.634 -7.627
201706 -6.102 103.029 -7.651
201709 -6.085 103.345 -7.606
201712 1.687 103.345 2.109
201803 0.382 105.004 0.470
201806 1.397 105.557 1.710
201809 3.376 105.636 4.128
201812 3.262 105.399 3.998
201903 2.904 106.979 3.507
201906 2.577 107.690 3.091
201909 2.346 107.611 2.816
201912 2.694 107.769 3.229
202003 4.667 107.927 5.586
202006 4.607 108.401 5.490
202009 4.228 108.164 5.050
202012 3.841 108.559 4.571
202103 5.507 110.298 6.450
202106 5.031 111.720 5.817
202109 4.951 112.905 5.665
202112 9.295 113.774 10.554
202203 9.273 117.646 10.182
202206 11.943 120.806 12.771
202209 12.162 120.648 13.022
202212 10.882 120.964 11.621
202303 10.167 122.702 10.704
202306 9.364 124.203 9.739
202309 9.176 125.230 9.465
202312 11.290 125.072 11.661
202403 10.823 126.258 11.074
202406 10.363 127.522 10.498
202409 9.484 127.285 9.625
202412 9.434 127.364 9.569
202503 8.502 129.181 8.502

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Xenon Pharmaceuticals  (FRA:XP0) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Xenon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=26.20/4.17
=6.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Xenon Pharmaceuticals was 26.02. The lowest was 6.56. And the median was 17.86.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Xenon Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Xenon Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Xenon Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Xenon Pharmaceuticals Headlines

No Headlines